Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 13.081% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Cn1cnnc1SCC(C)(C)NS(=O)(=O)c1ccc(Cl)cc1
b) O=C(CCNS(=O)(=O)c1ccc(Br)cc1)NCC1CCCO1
c) CC1CCN(CCCOc2ccc(Br)cc2Cl)CC1
Answer: b. O=C(CCNS(=O)(=O)c1ccc(Br)cc1)NCC1CCCO1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCNS(=O)(=O)c1ccc(Br)cc1)NCC1CCCO1
O=C(CCNS(=O)(=O)c1ccc(Br)cc1)NCC1CCCO1
3-[(4-bromophenyl)sulfonylamino]-N-(oxolan-2-ylmethyl)propanamide